Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
SMAD family proteins: the current knowledge on their expression and potential role in neoplastic diseases.
Current and future drugs for treatment of MS-associated bladder dysfunction.
[Cannabinoid drugs for neurological diseases: what is behind?].
Revisiting The Multiple Sclerosis Functional Composite: proceedings from the National Multiple Sclerosis Society (NMSS) Task Force on Clinical Disability Measures.
Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy.
The "liberation procedure" for multiple sclerosis: sacrificing science at the altar of consumer demand.
Low dose naltrexone therapy in multiple sclerosis.
Client-centred therapy in multiple sclerosis: More intensive diagnostic evaluation and less intensive treatment.
Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis.
Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning.
[Multiple sclerosis: new approaches to comprehensive treatment and rehabilitation using the method of reflexology].
Outcome and survival of asymptomatic PML in natalizumab-treated MS patients.
Integration of MicroRNA Databases to Study MicroRNAs Associated with Multiple Sclerosis.
Minocin
Modest familial risks for multiple sclerosis: a registry-based study of the population of Sweden.
Extension Trial Data Shows Cladribine Benefits Persist in RRMS Patients
Safety, tolerability, and efficacy of orally administered cannabinoids in MS.
Massive CNS monocytic infiltration at autopsy in an alemtuzumab-treated patient with NMO.
T-cell vaccination in Crohn's disease: principles and presentation of the first two cases.
Predictors of disease activity in 857 patients with MS treated with interferon beta-1b.
Treating multiple sclerosis with monoclonal antibodies: a 2013 update.
Painful Tonic Spasm in Neuromyelitis Optica: Incidence, Diagnostic Utility, and Clinical Characteristics.
Recommendations for diagnosis and management of multiple sclerosis.
Seeing optic neuritis through myopic eyes.
Time to see the light.
Pages
« first
‹ previous
…
131
132
133
134
135
136
137
138
139
…
next ›
last »